Skip to main content

and
  1. Article

    Open Access

    Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer

    Retinoid X Receptor Gamma (RXRG) is a member of the nuclear receptor superfamily and plays a role in tumour suppression. This study aims to explore the prognostic significance of RXRG in breast cancer.

    Chitra Joseph, Sara Al-Izzi, Mansour Alsaleem, Sasagu Kurozumi in British Journal of Cancer (2019)

  2. No Access

    Article

    Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer

    CD133/ prominin 1 is a cancer stem cell marker associated with cancer progression and patient outcome in a variety of solid tumours, but its role in invasive breast cancer (BC) remains obscure. The current stu...

    Chitra Joseph, Maariya Arshad, Sasagu Kurozomi in Breast Cancer Research and Treatment (2019)